PRA Group Targets $1.2B Portfolio Buy in 2025 Amid Cost Cuts and Overhaul

Key Highlights from PRA Group’s Q3 2025 Earnings Call

During the third quarter of 2025, PRA Group, Inc. (PRAA) delivered a set of financial results that reflected both strong performance and challenges in certain areas. The company's leadership provided detailed insights into its operations, financials, and strategic direction during the earnings call.

Management Perspective

CEO Martin Sjolund emphasized the growth in cash collections, which rose by 14% year-over-year to $542 million. This increase was attributed to strong recent portfolio purchases and continued progress in operational initiatives. He noted that global collections exceeded expectations by 8%, with the U.S. outperforming by 6% and Europe by 10%. Despite more selective portfolio purchases, the company remains on track to meet its annual investment goal of $1.2 billion.

Sjolund also addressed a nonrecurring noncash goodwill impairment charge of $413 million recorded in the third quarter, primarily in Europe. He clarified that this charge was due to accounting rules rather than any underlying business issues, as the European operations continue to perform well.

In terms of cost efficiency, Sjolund mentioned a reduction in U.S. headcount by over 115 employees, with total agent headcount declining by 25% year-over-year. The company aims for $20 million in gross annualized cost savings, though $3 million is expected to be offset by increased outsourcing costs. Additionally, PRA Group has implemented a new cross-functional U.S. team, established a second talent hub in Charlotte, North Carolina, and made progress on IT modernization, including AI application pilots.

CFO Rakesh Sehgal reported that the company purchased $255 million in portfolios during the quarter, with 60% in the Americas and 40% in Europe. He highlighted that the ERC (Estimated Recoverable Claims) at the end of the quarter reached $8.4 billion, up 15% year-over-year and 1% sequentially. Sehgal also explained that the goodwill impairment was triggered by the sustained decline in the company’s stock price.

Financial Performance

Portfolio revenue came in at $310 million, with portfolio income growing 20% year-over-year to $259 million. Adjusted EBITDA for the last 12 months was $1.3 billion, up 15% compared to the prior year. However, the company reported a net loss of $408 million for the quarter, although adjusted net income, excluding the goodwill impairment, was $21 million or $0.53 per diluted share.

Operating expenses for the quarter were $627 million, with adjusted operating expenses (excluding the goodwill charge) at $214 million, up 12% from the previous year. Legal collection costs reached $47 million, with expectations of about $40 million in Q4. Net leverage stood at 2.8x as of September 30, with $3.2 billion in total committed capital under credit facilities and $1.2 billion in total availability. During the quarter, the company issued a EUR 300 million, seven-year euro-denominated bond.

Analyst Questions and Management Responses

Several analysts raised questions during the Q&A session. David Scharf from Citizens JMP Securities asked whether similar contract modifications, such as the $15 million payment, would occur again. Sjolund responded that this was an unusual, one-time situation.

Another question focused on the timeline for GAAP profitability from portfolio income alone. Sehgal explained that purchase price multiples have been increasing, and operational improvements could lead to higher collections than originally underwritten.

Mark Hughes from Truist Securities inquired about the accounting treatment of the $15 million adjustment, to which Sehgal replied that there was a benefit associated with it, including an ERC benefit. Hughes also asked about the relationship between the goodwill charge and performance, and Sjolund reiterated that the European business continues to perform well, with the goodwill charge being a mechanical accounting adjustment.

Robert Dodd from Raymond James questioned the uniqueness of the $15 million contract revision, and Sjolund confirmed it was a unique situation not expected to recur frequently. Dodd also asked about the impact of COVID vintages, and Sjolund explained that these were underwritten as the company emerged from the pandemic.

Dodd further inquired about investment dynamics in Southern Europe, and Sehgal noted that the competitive landscape there has stabilized, allowing for successful capital deployment.

Sentiment and Outlook

Analysts expressed concerns over nonrecurring adjustments, capital allocation, the impact of the goodwill impairment, portfolio mix, and the outlook for cash collections growth. Their tone was probing, focusing on clarity around unusual events and forward-looking risks.

Management maintained a confident and explanatory tone in their prepared remarks, with Sjolund emphasizing ongoing progress and operational improvements. In Q&A, responses remained measured and detailed, often reiterating the singular nature of events and the stability of core operations.

Compared to the previous quarter, management’s tone remained steady, but analysts appeared more focused on exceptional items and their implications.

Quarter-over-Quarter Comparison

The current quarter saw a sharper focus on cost reduction and operational restructuring, with explicit headcount reductions and the rollout of a new U.S. team structure. In contrast, the previous quarter emphasized the momentum of cash-generating initiatives and early steps toward U.S. transformation.

Guidance for $1.2 billion in portfolio purchases, high single-digit cash collections growth, and 60%+ cash efficiency was reaffirmed in both quarters. However, the current quarter included a substantial noncash goodwill impairment, a new development not seen in the prior quarter.

Analysts in the current quarter centered their questions on nonrecurring events, capital allocation, and the impact of COVID-vintage portfolios, while previously, attention was more broadly on operational execution and cost structures.

Risks and Concerns

Management cited the sustained decline in stock price as the trigger for the $413 million goodwill impairment, clarifying no operational or portfolio impact. Analysts questioned the repeatability of unique contract adjustments and the ongoing underperformance of COVID-era vintages.

Management noted that COVID vintages now comprise only about 10% of global ERC and are expected to become a smaller percentage over time. Competitive dynamics in Southern Europe, legal collection costs, and U.S. consumer health were identified as ongoing monitoring points.

Final Takeaway

PRA Group’s third quarter centered on executing strategic priorities, including aggressive cost reductions, operational restructuring in the U.S., and IT modernization, while reaffirming full-year targets for portfolio purchases, cash collections growth, and efficiency. Despite a large noncash goodwill impairment driven by stock price declines, management emphasized the continued overperformance of European operations, the positive trajectory of adjusted EBITDA, and disciplined capital allocation—with share buybacks remaining under consideration depending on future opportunities.

The team remains focused on enhancing operational leverage, mitigating exposure to underperforming vintages, and capitalizing on stabilized market dynamics, particularly in Southern Europe.